Skip to content
Bullfrog AI
  • Home
  • Technology
  • Solutions
    • bfPREP™ | AI-Powered Data Prep Platform
    • BullFrog Data Networks® — AI-ML Multi-Omics Insight Platform
    • CNS Target Discovery
    • Drug Pipeline
  • News
  • Investors
  • Resources
    • Blog
    • Frequently Asked Questions (FAQs)  
    • Webinars
    • White Papers
  • About
    • Careers
    • Leadership
    • Events
  • Contact
  • Home
  • Technology
  • Solutions
    • bfPREP™ | AI-Powered Data Prep Platform
    • BullFrog Data Networks® — AI-ML Multi-Omics Insight Platform
    • CNS Target Discovery
    • Drug Pipeline
  • News
  • Investors
  • Resources
    • Blog
    • Frequently Asked Questions (FAQs)  
    • Webinars
    • White Papers
  • About
    • Careers
    • Leadership
    • Events
  • Contact
Leadership

Leadership

Meet BullFrog’s AI-Driven Drug Development Leadership

The BullFrog AI leadership team consists of exceptional life science industry leaders, AI technologists, scientists, physicians, and advisors: proven leaders who are determined to revolutionize drug development.

MESSAGE FROM THE EXPERTS

blank

Let us help you determine the right drug for the right patient at the right dose.” 

blank

Vin Singh

CEO 

blank

AI can be used to identify predictors of drug response that may not be hypothesized by scientists and clinicians.”

blank

Dr. Kristin Bigos

Senior Director CNS

frog print

The Team  

Vin Singh

Chairman and CEO

Josh Blacher, MBA

Chief Financial Officer

John Stewart

Senior Vice President of Commercial Sales

Eric Roos

Senior Vice President of Business Development and Strategy

JT Koffenberger

Chief Information Officer

Thomas Hazel, Ph.D.

Vice President of Scientific Operations

Kristin Bigos, Ph.D.

Senior Director CNS
frog print

Advisors

Florin Rotar

Strategic Business Advisor

Cetin Savkli, Ph.D. 

Chief AI Advisor

John Baldoni, Ph. D.

Strategic Pharma Advisor

Lopa Mishra, M.D.

Strategic Advisor (Liver Disease)

Gregory Riggins, M.D./Ph.D.

Scientific Advisor (Neurosurgery and Oncology)

Randy J. Seeley, Ph.D.

Scientific Advisor (Obesity / Metabolic Disorders)

Gwenn Smith, Ph.D.

Scientific Advisor (Neuropsychiatric and Neurodegenerative Diseases)

Leap into the future of AI-powered drug development with BullFrog AI. 

Hop On

© 2026 BullFrog AI Holdings, Inc.

  • Terms of Use
  • Privacy Policy
  • DMCA Notice
  • Accessibility Statement
LinkedIn YouTube